top of page
CLINICAL STUDIES
Kidney transplantation
OPEN ENROLLMENT
Mercury.
A Phase 3 Prospective, Randomized, Multi-center, Open-label, Controlled Trial to Assess the Efficacy and Safety of Cellular Immunotherapy with MDR-101 for Induction of Immune Tolerance in Recipients of HLA-matched, Living Donor Kidney Transplants
Funded by Medeor Therapeutics, Inc
Read
Read
OPEN ENROLLMENT
A randomized double-blind placebo-controlled study to evaluate the efficacy and safety of CINRYZE® (C1 esterase inhibitor [human]) for the treatment of acute antibody-mediated rejection in kidney transplant patients.
Funded by Shire ViroPharma, Inc..
Read
OPEN ENROLLMENT
A Phase 2a, Randomized, Open-Label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of Bleselumab in
Preventing the Recurrence of Focal Segmental Glomerulosclerosis in de novo Kidney Transplant Recipients.
Funded by Astellas Pharma Global Development, Inc.
Read
COMPLETED
A Phase 2a, Randomized, Open-Label, Active Control, Multi- Center Study to Assess the Efficacy and Safety of ASKP1240 in de novo Kidney Transplant Recipients
Funded by Astellas Pharma Global Development, Inc.
Read results
COMPLETED
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial to Evaluate the Efficacy and Safety of a Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seronegative Kidney Transplant Recipients Receiving an Organ from a CMV-Seropositive Donor.
Funded by Astellas Pharma Global Development, Inc.
bottom of page